BioLife Solutions (BLFS) Tops Q2 EPS by 88c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of $0.91, $0.88 better than the analyst estimate of $0.03. Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.51 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
- DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
